Neural drug delivery is the next step beyond the basic addition of growth factors to nerve guidance conduits . Drug delivery systems allow the rate of growth factor release to be regulated over time, which is critical for creating an environment more closely representative of in vivo development environments. ref Lavik, E. and R. Langer, Tissue engineering current state and perspectives. Applied Microbiology Biotechnology, 2004. 65 p. 1 8 ref Delivery systems can have many different uses however, the emphasis of the discussion here will be on the need for drug delivery systems in nervous system injuries . First principles A major challenge of delivering growth factors to lesions in the spinal cord is the high clearance and removal due to the high turnover rate of the cerebrospinal fluid . One way to overcome this is to use a drug delivery system that slowly releases the growth factors over a prolonged period of time. ref name taylor Taylor, S.J., J.W. McDonald, and S.E. Sakiyama Elbert, Controlled release of neurotrophin 3 from fibrin gels from spinal cord injury. Journal of Controlled Release, 2004. 98 p. 281 294. ref One previously developed affinity based drug delivery system regulates the slow release of growth factors by binding them to heparin in fibrin gels. In addition to the fibrin gel there are three main components to the heparin based delivery system HBDS a synthetic linker peptide, the polysulfated glycosaminoglycan heparin, and the growth factors being delivered. ref name taylor The synthetic linker peptide is covalently crosslinked to the fibrin gels and is noncovalently linked to heparin, which noncovalently links the desired growth factor to be delivered. The release of the growth factor from heparin is mediated by cell activated plasmin degradation. When axons extend into the gel, they activate the conversion of plasminogen to plasmin, thereby initiating plasmin degradation of the fibrin gel and release of a growth factor such as NT 3 . This drug d ... more details
Refimprove date June 2008 Infobox Disease Name Antithrombin III deficiency Image Caption DiseasesDB 783 ICD10 ICD10 D 68 80 d 65 ICD9 ICD9 289.81 ICDO OMIM 613118 MedlinePlus eMedicineSubj ped eMedicineTopic 119 MeshID D020152 Antithrombin III deficiency is a rare disease rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism . Inheritance is usually autosomal Dominance genetics dominant , though a few recessive cases have been noted. ref OMIM 107300 ref The disorder was first described by Egeberg in 1965. ref Egeberg O. 1965 Inherited antithrombin deficiency causing thrombophilia . Thromb Diath Haemorrh. 13 516 520. PMID 14347873. ref The patients are treated with anticoagulant s or, more rarely, with antithrombin concentrate. In renal failure , especially nephrotic syndrome , antithrombin is lost in the urine, leading to a higher activity of Factor II and Factor X and in increased tendency to thrombosis . Heparin resistance Patients with AT3 deficiency need higher doses of heparin. AT3 is known to slowly break up fibrin and factor X. When heparin binds to AT3, AT3 will break up fibrin and factor X faster. AT3 is not dependent on vitamin K so unlike warfarin, giving vitamin K will not reverse the effects of heparin. Heparin is used in bridge therapy when initiating a patient on warfarin when in a hospital setting. It can be used in DVT prophylaxis and treatment, acute coronary syndromes, and ST segment elevated MI. See also Antithrombin ATryn References reflist External links http www.med.uiuc.edu hematology PtAntithrombin.htm Information on antithrombin from UIUC http www.nattinfo.org Non profit advocacy group for patients and families with antithrombin deficiency Hematology Disorders of globin and globulin proteins Category Serpinopathies Category Rare diseases Category Coagulopathies disease stub pt Defici ncia de antitrombina III ... more details
The dysfibrinogenemias are a group of Dominance genetics autosomal dominant disorders of qualitatively abnormal fibrinogen s. ref http emedicine.medscape.com article 199723 overview ref There are more than 350 different fibrinogen abnormalities, each named after the place where it was discovered. ref cite book author McDonagh, J chapter Dysfibrinogenemia and other disorders of fibrinogen structure or function editor Colman R, Hirsh J, Marder V, Clowes A, George J title Hemostasis and Thrombosis edition 4th location Philadelphia, PA publisher Lippincott Williams & Wilkins year 2001 pages 855 892 ref Each dysfibrinogenemia is associated with slightly different effects on the thrombin time and on normal clotting. Some dysfibrinogenemias cause abnormal bleeding or even thrombosis , while others have no effect on either bleeding or thrombosis. ref cite journal url http www.archivesofpathology.org doi full 10.1043 0003 9985 282002 29126 3C1387 3ADAT 3E2.0.CO 3B2 journal Archives of Pathology & Laboratory Medicine title Dysfibrinogenemia and Thrombosis volume 126 issue 11 year 2002 pages 1387 1390 author Hayes T pmid 12421146 doi 10.1043 0003 9985 2002 126 1387 DAT 2.0.CO 2 ref Some examples are Amsterdam is a major defect, characterized by aggregation of fibrin monomer s, prolonged thrombin time, and an inhibitory effect on normal clotting but it is asymptomatic. Detroit is a major defect, there is fibrinopeptide release, the thrombin time is prolonged, there is an inhibitory effect on normal clotting and there is abnormal bleeding. Wiesbaden is a major defect, there is aggregation of fibrin monomers, the thrombin time is prolonged, there is an inhibitory effect on normal clotting and there is both bleeding and thrombosis. References reflist Diseases of RBCs and megakaryocytes Category Coagulopathies Category Autosomal dominant disorders Category Rare diseases disease stub ... more details
laysource laydate quote ref See also Fibrin References reflist Further reading refbegin 2 PBB Further reading citations cite journal author Doolittle RF title Fibrinogen and fibrin. journal Annu. Rev ... into fibrin ogen structure and function. journal Vox Sang. volume 83 Suppl 1 issue pages 375 82 ... determinants of fibrin structure and function relevance to clinical disease. journal Arterioscler ... cite journal author Lord ST title Fibrinogen and fibrin scaffold proteins ... more details
DISPLAYTITLE Indium sup 111 sup In biciromab Drugbox Verifiedfields changed verifiedrevid 458273546 drug name Indium sup 111 sup In biciromab Monoclonal antibody data type mab mab type Fab source o target Fibrin II, beta chain Clinical data tradename pregnancy AU pregnancy US pregnancy category N A legal AU legal CA legal UK legal US legal status Withdrawn routes of administration Pharmacokinetic data bioavailability protein bound metabolism elimination half life excretion Identifiers ChemSpiderID Ref chemspidercite correct chemspider ChemSpiderID NA CAS number Ref cascite changed ?? CAS number 138783 13 8 ATC prefix none ATC suffix PubChem DrugBank Ref drugbankcite correct drugbank DrugBank KEGG Ref keggcite correct kegg KEGG D03111 Chemical data chemical formula molecular weight Indium sup 111 sup In biciromab International Nonproprietary Name INN , trade name FibriScint , developed by Centocor was a pharmaceutical drug drug targeting fibrin , a protein involved in the clotting of blood. ref cite journal last King first David J. coauthors John R. Adair year 1999 title Recombinant antibodies for the diagnosis and therapy of human disease journal Current Opinion in Drug Discovery & Development volume 2 issue 2 page 112 issn 1367 6733 ref It was the Fab fragment of a mouse monoclonal antibody labelled with the radioisotope indium 111 for the diagnosis of thromboembolism , ref http www.answers.com topic centocor inc Answers.com Centocor Ortho Biotech Products, L.P. ref but was withdrawn during clinical trial s. ref http www.diagnosticimaging.com news display article 113619 1236557?verify 0 DiagnosticImaging.com Centocor withdraws imaging agent applications ref References reflist Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems Category Centocor Biciromab monoclonal antibody stub it Indium 111In biciromab ... more details
Orphan date October 2006 att May 2011 Image Gematogen.jpg thumb 250px Hematogen bar. Hematogen in Russian language Russian , sometimes transliterated as Gematogen is a Russia n candy bar , which is notable in that one of its main ingredients is black food albumin taken from processed fibrin defibrinated cow s blood . Other ingredients may vary, but usually they re sugar, milk, vanillin. It is often considered to be a medicinal product, and is used to treat or prevent low blood levels of iron and vitamin B12 e.g., for anemia or during pregnancy . Gematogen daily dose 50 grams for an adult is able to provide the body with the necessary quantity of vitamin A. Available without prescription but in a case of pregnancy or breastfeeding there is a medical consultation needed. Hematogen is not recommended for kids under 3 years old. External links http russian.lingualift.com blog gematogen blood candy Hematogen Bloody delicious confectionery stub Category Candy bars ka ru ... more details
Orphan date January 2008 Hepatization is conversion into a substance resembling the liver a state of the lungs when gorged with effused matter, so that they are no longer pervious to the air. Red hepatization is when there are red blood cells , neutrophils , and fibrin in the pulmonary alveolus alveoli it precedes gray hepatization , where the red cells have been broken down leaving a fibrinosuppurative exudate . The main cause is lobar pneumonia . Further reading http books.google.com books?id C1aRv0SoaQEC&pg PA174&lpg PA174&dq Hepatization&source web&ots kpA8NrZNGv&sig tB3chZg3xjey q1vPza JHGuem4 PPA177,M1 Lectures on the diseases of the lungs and heart By Thomas Davies http books.google.com books?id rh8CAAAAYAAJ&pg PA137&lpg PA137&dq Hepatization&source web&ots vZyaB3JGla&sig CWj4J4uh8j0pAVxU2RVA54nxv3M PPA137,M1 Medical Times 1841 http books.google.com books?id e6LOdr619kC&pg PA291&lpg PA291&dq hepatization&source web&ots dFrSx7rNEt&sig CKVRtgof0yTma rpC59asIytHg PPA289,M1 London Medical Gazette, December 8, 1843 Category Lung disorders Med stub ... more details
Clot retraction is the shrinking of a blood clot over a number of days. In so doing, the edges of the blood vessel wall at the point of injury are slowly brought together again to repair the damage. Clot retraction is dependent on release of multiple coagulation factors from platelets trapped in the fibrin mesh of the clot. Thus, failure to retract can be a sign of thrombocytopenia or a rare condition called Thrombasthenia. Further reading cite book title Human Physiology The Mechanisms of Body Function author Arthur J. Vander, James H. Sherman, and Dorothy S. Luciano publisher McGraw Hill date 1970 location pages 502 chapter Clot Retraction cite book title Hemostasis in Cardiac editor Safuh Attar pages 118&ndash 120 publisher Blackwell Publishing date 1999 isbn 0879934107 isbn13 9780879934101 author Nikolaos Skubas and George J. Despotis chapter Intraoperative Diagnosis and Therapy of Hemostatis Abnormalities with Cardiac Surgery External links MeshName Clot retraction Category Coagulation system treatment stub Blood physiology ... more details
unreferenced date December 2011 A coagulation screen is a combination of Screening medicine screening laboratory tests , designed to provide rapid non specific information, which allows an initial broad categorization of haemostatic problems. The basic screen consists of platelet count bleeding time for platelet function PR prothrombin ratio for extrinsic pathway aPTT Activated Partial Thromboplastin time for the intrinsic pathway Thrombin clotting time TCT or fibrinogen assay for final common pathway Two other tests are regularly performed at the same time blood count , to detect other hematological abnormalities liver function tests to exclude liver disease as a cause of coagulation factor deficiency These tests may miss mild abnormalities but they will detect major disorders. The results of these screening tests, in conjunction with the clinical history especially bleeding history , will then direct the selection of further, more detailed and specific coagulation tests, such as specific factor assays, like fibrin degradation product s, D dimer , thrombin time , platelet aggregation , or specific factor inhibitor assays, like Protein C , TFPI , Antithrombin etc. Category Blood tests ... more details
Image Cardiac amyloidosis very high mag movat.jpg thumb right 200px Movat s stain showing amyloid brown and fibrosis yellow of the heart. In pathology , the Movat s stain is a staining method in histology that is based on Alcian blue . ref Modified Movat s Pentachrome Stain. University of Pennsylvania. URL http www.med.upenn.edu mcrc histology core movat.shtml http www.med.upenn.edu mcrc histology core movat.shtml . Accessed on 4 December 2009. ref It is used in cardiovascular pathology . Interpretation Black nuclei, elastic fibres Yellow collagen, reticular fibers Blue ground substance, mucin Bright red fibrin Red muscle Additional images gallery Image Myxomatous aortic valve.jpg Movat s stain demonstrating thickening of the spongiosa layer blue in myxomatous degeneration of the aortic valve . gallery References reflist See also Cardiovascular disease pathology stub Stains Category Staining ... more details
Wikify date September 2010 Orphan date September 2010 Primary fibrinogenolysis is the pathological lysis of fibrinogen characterized with a low fibrinogen, high fibrin degradation products, prolonged prothrombin time and activated partial thromboplastin time, a normal platelet count and absence of microcirculatory thrombosis ref Biron Andr ani C, Morau E, Schved JF, H don B, Dechaud H. Amniotic fluid embolism with haemostasis complications primary fibrinogenolysis or disseminated intravascular coagulation? Pathophysiol Haemost Thromb. 2003 33 3 170 171 ref . Diagnosis The most important differential diagnosis is disseminated intravascular coagulation , which is characterized with similar features but presence of a low platelet count and microcirculatory thrombosis. Antifibrinolytic treatments are contraindicated in patients with disseminated intravascular coagulation while they are useful in the treatment of primary fibrinogenolysis. References references DEFAULTSORT Primary Fibrinogenolysis Category Coagulopathies sr ... more details
A cricoidectomy is the surgical excision of the cricoid cartilage . The excision can often be performed under local anaesthetic and can either be partial or total. The procedure may be necessary as a treatment of pulmonary aspiration , to prevent progression to aspiration pneumonia . As the cricoid cartilage is the narrowest part of the Vertebrate trachea trachea , it is also a common point of a blockage or narrowing stenosis . ref name partial cricoidectomy http jtcs.ctsnetjournals.org cgi content full 121 1 0068?maxtoshow &HITS 10&hits 10&RESULTFORMAT &fulltext cricoid&searchid 1&FIRSTINDEX 0&resourcetype HWFIG BDY Introduction Paolo Macchiarini Jean Philippe Verhoye Alain Chapelier Elie Fadel Philippe Dartevelle 2000 Partial cricoidectomy with primary thyrotracheal anastomosis for postintubation subglottic stenosis J Thorac Cardiovasc Surg ref ref Michihiko Sonea1 Tsutomu Nakashimaa1 Noriyuki Yanagita 1995 Laryngotracheal separation under local anaesthesia for intractable salivary aspiration cricoidectomy with fibrin glue support The Journal of Laryngology & Otology Cambridge University Press ref References reflist treatment stub Respiratory system procedures Category Trachea surgery ... more details
Image Acute myocardial infarction with contraction band necrosis 1 PTAH.JPG thumb right 250px Phosphotungstic acid haematoxylin staining demonstrating contraction band necrosis in an individual that had a myocardial infarction heart attack . Phosphotungstic acid haematoxylin PTAH is a mix of haematoxylin with phosphotungstic acid , used in histology for staining . It stains some tissue in contrasting colors in a way similar to haematoxylin and eosin stain , as phosphotungstic acid binds to tissue protein s. It is used to show gliosis in the central nervous system , tumour s of skeletal muscle s, and fibrin deposits in lesion s. Muscle is stained blue black to dark brown, connective tissue is pale orange pink to brownish red, fibrin and neuroglia stain deep blue, coarse elastic fibers show as purple, and bone and cartilage obtain yellowish to brownish red color. PTAH is ideal for demonstrating striated muscle fibers and mitochondria , often without a counterstain . As such, it is used to identify contraction bands, as seen in contraction band necrosis . ref name pmid10392641 cite journal title Pathologic detection of early myocardial infarction a critical review of the evolution and usefulness of modern techniques journal Mod. Pathol. volume 12 issue 6 pages 635 45 year 1999 month June pmid 10392641 doi url author1 Vargas SO author2 Sampson BA author3 Schoen FJ author separator , author name separator ref PTAH stains ependymomas while it does not stain choroid plexus papillomas, providing one means of differentiating these tumors. This technique has been largely replaced by immunohistochemistry techniques. ref name Carson cite book title Histotechnology a self instructional text author1 Carson,Frieda L author2 Hladik,Christa. ref Staining Principle There is much more phosphotungstic acid in the solution than hematein. The phosphotungstic acid binds all of the available hematein to form a blue lake pigment . This lake stains the muscle cross striations, fibrin, nuclei ... more details
and plasminogen binding sites within fibrin ogen alpha C domains journal Biochemistry volume 40 issue ... Jul. title Localization of the binding site of tissue type plasminogen activator to fibrin journal ... and fibrin journal Annu. Rev. Biochem. volume 53 issue pages 195 229 year 1984 pmid 6383194 doi 10.1146 ... author Everse SJ title New insights into fibrin ogen structure and function journal Vox Sang. volume ... PJ title Genetic and environmental determinants of fibrin structure and function relevance to clinical ... and fibrin scaffold proteins in hemostasis journal Curr. Opin. Hematol. volume 14 issue 3 pages 236 ... HM, McKee PA title Localization of the alpha chain cross link acceptor sites of human fibrin journal ... N glycosylation at A alpha asparagine 139. Impaired fibrin gel formation but normal fibrin facilitated ..., fibrinogen Caracas II, characterized by impaired fibrin gel formation journal J. Biol ... more details
Pfam box Symbol Fibrnctn1 Name Fibronectin, type I Pfam PF00039 InterPro IPR000083 SMART SM00058 PROSITE PDOC00965 PDB PDB 1e88 PDB 1e8b PDB 1fbr PDB 1o9a PDB 1qgb PDB 1qo6 PDB 1tpg PDB 1tpm PDB 1tpn PDB 2fn2 Fibronectin, type I repeats are one of the three repeats found in the fibronectin protein. Fibronectin is a plasma protein that binds cell surfaces and various compounds including collagen , fibrin , heparin , DNA, and actin . Type I domain FN1 is approximately 40 residues in length. Four conserved cysteines are involved in disulfide bond s. The 3D structure of the FN1 domain has been determined ref name PUB00004065 cite journal author Campbell ID, Baron M, Norman D, Willis A title Structure of the fibronectin type 1 module journal Nature volume 345 issue 6276 pages 642 646 year 1990 pmid 2112232 doi 10.1038 345642a0 ref ref name PUB00003289 cite journal author Driscoll PC, Harvey TS, Campbell ID, Baron M, Dudgeon TJ, Downing AK, Smith BO title Solution structure of the fibrin binding finger domain of tissue type plasminogen activator determined by 1H nuclear magnetic resonance journal J. Mol. Biol. volume 225 issue 3 pages 821 833 year 1992 pmid 1602484 doi 10.1016 0022 2836 92 90403 7 ref ref name PUB00005265 cite journal author Driscoll PC, Campbell ID, Dudgeon TJ, Downing AK, Smith BO title The solution structure and backbone dynamics of the fibronectin type I and epidermal growth factor like pair of modules of tissue type plasminogen activator journal Structure volume 3 issue 8 pages 823 833 year 1995 pmid 7582899 doi 10.1016 S0969 2126 01 00217 9 ref . It consists of two antiparallel beta sheets, first a double stranded one, that is linked by a disulfide bond to a triple stranded beta sheet. The second conserved disulfide bridge links the C terminal adjacent strands of the domain. In human tissue plasminogen activator chain A the FN1 domain together with the following epidermal growth factor EGF like domain are involved in fibrin binding ref name PUB00002 ... more details
ref Cite journal author Sclafani AP title Applications of platelet rich fibrin matrix in facial ... doi 10.1055 s 0029 1242033 url ref ref Cite journal author Sclafani AP title Platelet rich fibrin ... more details
D dimer is a fibrin degradation product or FDP , a small protein fragment present in the blood after a thrombus blood clot is degraded by fibrinolysis . It is so named because it contains two crosslinked D fragments of the fibrinogen protein. ref name Adam cite journal author Adam SS, Key NS, Greenberg CS title D dimer antigen current concepts and future prospects journal Blood volume 113 issue 13 pages 2878 2887 year 2009 month March pmid 19008457 doi 10.1182 blood 2008 06 165845 url http bloodjournal.hematologylibrary.org cgi content full 113 13 2878 ref D dimer concentration may be determined by a blood test to help diagnose thrombosis . Since its introduction in the 1990s, it has become an important test performed in patients suspected of thrombotic disorders. While a negative result practically rules out thrombosis, a positive result can indicate thrombosis but does not rule out other potential causes. Its main use, therefore, is to exclude thromboembolic disease where the probability is low. In addition, it is used in the diagnosis of the blood disorder disseminated intravascular coagulation . ref name Adam Principles Image D dimer.png right framed Principles of D dimer testing Coagulation , the formation of a blood clot or thrombus , occurs when the proteins of the coagulation cascade are activated, either by contact with damaged blood vessel wall intrinsic pathway or by activation of factor VII by tissue factor tissue activating factors . Both pathways lead to the generation of thrombin , an enzyme that turns the soluble blood protein fibrin ogen into fibrin, which aggregates into proteofibrils. Another thrombin generated enzyme, factor XIII , then crosslinks the fibrin ... of fibrinolysis , cleaves the fibrin gel in a number of places. The resultant fragments, high molecular ... polymers fibrin degradation product s or FDPs . The cross link between two D fragments remains intact, however, and these are exposed on the surface when the fibrin fragments are sufficiently ... more details
and last step is called coagulation or blood clotting. Coagulation reinforces the platelet plug with fibrin ... seconds until the first fibrin strands begin to intersperse among the wound. After several minutes the platelet plug is completely formed by fibrin. ref Boon, G. D. An Overview of Hemostasis. Toxicologic ... to fibrin , and its addition to the platelet plug secondary hemostasis . Coagulation The third and final step in this rapid response reinforces the platelet plug. Coagulation or blood clotting uses fibrin threads that act as a glue for the sticky platelets. As the fibrin mesh begins to form the blood ... to form a collagen fiber called fibrin. FibrinFibrin mesh is then produced all around the platelet plug, which helps hold the fibrin in place. Once this begins, red and white blood cells caught up in the fibrin mesh which causes the clot to become even stronger. ref name clemetson Types of Hemostasis ... of the body to create the platelet plug and the fibrin mesh that ultimately stops the bleeding ... more details
Sclafani AP title Applications of platelet rich fibrin matrix in facial plastic surgery journal Facial ... url ref ref Cite journal author Sclafani AP title Platelet rich fibrin matrix for improvement of deep ... more details
FDP may refer to Political parties Free Democratic Party Germany FDP.The Liberals , a political party in Switzerland Free Democratic Party of Switzerland , a predecessor to FDP. Free Democratic Party GDR of the former East Germany Florida Democratic Party Biology and Medicine A metabolite fructose 1,6 bisphosphate in glycolysis . Fibrin degradation products , a blood test of coagulation The muscle flexor digitorum profundus The Fixed Dose Procedure , a method of testing the toxicity of substances. Computer and Networks Foundry Discovery Protocol Other meanings Fresh Del Monte Produce Inc., traded on the New York Stock Exchange under the stock symbol symbol FDP Filho da puta , a general purpose insult in Portuguese speaking countries analogous with the use of SOB to mean bitch insult son of a bitch in English. The Fixed Dose Procedure , a method of testing the toxicity of substances. Flight Data Processor, in air traffic control air traffic management Funded Decommissioning Programme UK , an agreement between the Secretary of State and a new nucelar power station operator setting out costs for decommissioning and waste management and how the operator will ensure that sufficient finances for those activities exist. the Faculty Development Program of the Commission on Higher Education Philippines . External links http acronyms.thefreedictionary.com FDP FDP entry on the http acronyms.thefreedictionary.com acronyms.thefreedictionary.com website disambig als FDP de FDP eo FDP es FDP fr FDP it FDP nl FDP ja FDP pl FDP FDP ... more details
Roth s spots are retina l hemorrhage s with white or pale centers composed of coagulate d fibrin . They are typically observed via fundoscopy using an ophthalmoscope to view inside the human eye eye or slit lamp exam. They are usually caused by immune complex mediated vasculitis often resulting from bacterial endocarditis . Roth s spots may be observed in leukemia , diabetes , subacute bacterial endocarditis , pernicious anaemia , ischemia ischemic events , and rarely in HIV retinopathy. Roth s spots are named after Moritz Roth . ref WhoNamedIt synd 2684 ref ref M. Roth. ber Netzhautaffectionen bei Wundfiebern. I. Die embolische Panophthalmitis. Deutsche Zeitschrift f r Chirurgie, Leipzig, 1872, 1 471 484. ref See also Osler s nodes Janeway lesion References reflist External links http www.nature.com eye journal v19 n5 fig tab 6701530f2.html Image at Nature.com Eponymous medical signs for eyes and ears Eponymous medical signs for cardiovascular system Category Diseases of the eye and adnexa Category Symptoms and signs Cardiac med sign stub es Manchas de Roth pl Plamki Rotha ... more details
Image Schizocyte smear 2009 12 22.JPG thumb right Peripheral blood MGG stain patient with hemolytic uremic syndrome A schistocyte or schizocyte from Greek language Greek schistos for divided or schistein for to split , and kytos for hollow or cell is a cell fragmentation fragmented part of a red blood cell . Schistocytes are typically irregularly shaped, jagged, and asymmetrical. A true schistocyte does not have central pallor. ref Amanda Cox et al. , http www.vet.uga.edu vpp clerk cox index.php Schistocytes A Brief Overview . Retrieved 23 August 2008. ref Schistocytes are sometimes referred to as helmet cells. Several microangiopathy microangiopathic diseases , including disseminated intravascular coagulation and thrombotic microangiopathies , generate fibrin strands that sever red blood cells as they try to move past a thrombus , creating schistocytes. Schistocytes are often seen in patients with hemolytic anemia . They are frequently a consequence of mechanical heart valve prostheses. See artificial heart valve Excessive schistocytes present in blood can be a sign of microangiopathic hemolytic anemia MAHA where the most common cause is aortic stenosis. References reflist pathology stub Abnormal clinical and laboratory findings Category Abnormal clinical and laboratory findings for RBCs ar de Fragmentozyt fr Schistocyte ... more details
Infobox Disease Name Portal vein thrombosis Image Pfortaderthrombose001.png Caption Portal vein thrombosis in computertomography. DiseasesDB ICD10 ICD10 I 81 i 80 ICD9 ICD9 452 ICDO OMIM MedlinePlus eMedicineSubj radio eMedicineTopic 571 MeshID Portal vein thrombosis is a form of venous thrombosis affecting the hepatic portal vein , which can lead to portal hypertension and reduction in the blood supply to the liver . Causes Causes can include pancreatitis , cirrhosis , diverticulitis , and cholangiocarcinoma . It is also a known Complication medicine complication of splenectomy . ref Ali Cadili, Chris de Gara, Complications of Splenectomy , The American Journal of Medicine , 2008, pp 371 375. ref Diagnosis The diagnosis of portal vein thrombosis is usually made by ultrasound , computed tomography with contrast or magnetic resonance imaging . D dimer levels in the blood blood may be elevated as a result of fibrin degradation. Treatment Treatments include anticoagulant s, Shunt medical shunt s, Coronary artery bypass surgery bypass surgery , and Organ transplant transplant s. See also Pylephlebitis References Reflist External links Commons category Portal vein thrombosis http www.merckmanuals.com home liver and gallbladder disorders blood vessel disorders of the liver veno occlusive disease of the liver.html Merck Vascular diseases DEFAULTSORT Portal Vein Thrombosis Category Hepatology Category Vascular diseases Category Diseases of veins, lymphatic vessels and lymph nodes disease stub de Pfortaderthrombose ... more details
About Ponceau 6R Ponceau disambiguation Unreferenced date February 2010 Image Ponceau 6R.png thumb right 200px Ponceau 6R Ponceau 6R , or Crystal ponceau 6R , Crystal scarlet , Brilliant crystal scarlet 6R , Acid Red 44 , or C.I. 16250 , is a red azo dye . It is soluble in water and slightly soluble in ethanol . It is used as a food dye , with E number E126. It is also used in histology , for staining fibrin with the MSB Trichrome stain. It usually comes as disodium salt. Amaranth dye Amaranth is a closely related azo dye, also usable in trichrome staining. SMILESCAS CAS 2766 77 0 SMILES OC1 C N N C3 C C CC C4 C4 CC C3 C2 C C C S O O O C C2 S O O O C C1 See also Ponceau family of Azo dyes DEFAULTSORT Ponceau 6r Category Azo dyes Category Food colorings Category Staining dyes Category Naphthalenesulfonates Category 2 Naphthols Organic compound stub Cell biology stub Ingredient stub bs E126 es Ponceau 6R fr Ponceau 6R hu Ponsz 6R pl P s 6R ... more details
products, including liquid Fibrin Sealant ref name Cohn Cohn, E.J. The history of plasma ... , solid Fibrin Foam and a Fibrin Film. ref name MacPhee MacPhee, M.J. et al. Tissue Sealants available ... exposed to this type of hepatitis. ref name Birnie Liquid Fibrin Sealant was used with significant ... to be very helpful at re connecting or anasthomosing severed nerves ref name Cohn . Fibrin Foam and thrombin ... malformations within the brain. Fibrin film was used to stop bleeding in various surgical applications .... ref name Birnie The first fibrinogen fibrin based product capable of stopping arterial hemorrhage, including fatal bleeding, was the Fibrin Sealant Bandage or Hemostatic Dressing HD invented by MacPhee ... ref name Holcomb Holcomb,J.B. & MacPhee,M.J. et al. Implications of New Dry Fibrin Sealant Technology ... more details
Encyclopedia
top
